Search & Filter

The Scottish Medicines Consortium (SMC) has accepted obinutuzumab (Gazyvaro) for the treatment of follicular lymphoma when used alongside bendamustine.

NHS England aims for an extra 5,000 people each year to survive cancer by 2019, a new report claims. The report sets out a number of measures to achieve this target, including investment in new radiotherapy machines, support for services to diagnose cancers earlier, and personalised care for patients.

More than 20 million UK adults are classified as physically inactive increasing their risk of heart disease and costing the UK health service as much as £1.2 billion each year according to a new report from the British Heart Foundation.

Using PET scans of the brain, University of Michigan researchers showed that dopamine falls and fluctuates at different times during a migraine headache. This could help scientists better understand dopamine-based therapies for migraines as well as a patient's behavior during an attack.

People with advanced pancreatic cancer in England whose first chemotherapy treatment has not been effective, or stopped working, are being denied access to a new second treatment option on the NHS following on from a NICE announcement.

The first patients have been enrolled into the ELIMINATE-AF study, pharmaceutical company Daiichi Sankyo Europe GmbH has said.

The UK Gout Society has joined forces with doctors, parliamentarians, doctors and other charities to help raise awareness of gout €“ the most common form of inflammatory arthritis worldwide, which now affects one in 40 people in the UK.

People with advanced pancreatic cancer in England whose first chemotherapy treatment has not been effective, or stopped working, are being denied access to a new second treatment option on the NHS following an announcement from NICE.

New drugs that could improve the lives of people with diabetes could be delayed for several years under a new system being introduced by NHS England at the end of the month.

A new 5mg twice daily oral tablet to reduce inflammation in adults with rheumatoid arthritis, tofacitinib citrate (Xeljanz), has been granted Marketing Authorisation by the European Commission and is now licensed in the UK. 

New drugs which could improve the lives of people with diabetes could be delayed for several years under a new system being introduced by NHS England at the end of the month.

Thyroid disease is a common disorder in pregnancy. In this article the authors, look at the manifestations, management and treatment options

Antibiotic prescribing in England has fallen for the first time. Dr Bianca Potterton considers why

Tobacco control expert Andrea Crossfield MBE considers the dramatic reductions in young people's smoking in recent years, especially while adult smoking rates are falling more slowly and smoking-related health inequalities persist

Pre-menopausal South Asian women could be more at risk of developing osteoporosis in later life than white Caucasian women, a new study in the Journal Bone reports.